UnitedHealth Group Hits New 52-Week High at $428.00

UnitedHealth Group, Inc. has reached a significant milestone by hitting a new 52-week high of USD 428.00 on July 1, 2026. This achievement highlights the company's resilience in the healthcare services sector, despite a one-year performance decline of 13.83%, contrasting with the S&P 500's gain of 20.74% during the same period. With a market capitalization of USD 235,106 million, UnitedHealth Group remains a prominent player in the large-cap category. The company's price-to-earnings (P/E) ratio stands at 18.00, reflecting its valuation relative to earnings. Additionally, UnitedHealth Group offers a dividend yield of 3.46%, appealing to income-focused investors. The company's financial health is further underscored by a debt-to-equity ratio of 0.55 and a return on equity of 13.61%, indicating effective management of its capital structure and profitability. The price-to-book ratio is noted at 2.50, providing insight into the company's valuation relative to its assets. Overall, UnitedHealth Group's recent performance and financial metrics underscore its position in the competitive healthcare services industry.